Article
Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition.
Neurobiology of disease - 1 Sept 2024
Huin Vincent, Blum David, Delforge Violette, Cailliau Emeline, Djeziri Sofia, Dujardin Kathy, Genet Alexandre, Viard Romain, Attarian Shahram, Bruneteau Gaelle, Cassereau Julien, Genestet Steeve, Kaminsky Anne-Laure, Soriani Marie-Hélène, Lefilliatre Mathilde, Couratier Philippe, Pittion-Vouyovitch Sophie, Esselin Florence, De La Cruz Elisa, Guy Nathalie, Kolev Ivan, Corcia Philippe, Cintas Pascal, Desnuelle Claude, Buée Luc, Danel-Brunaud Véronique, Devos David, Rolland Anne-Sophie
Abstract excerpt
Caffeine consumption outcomes on Amyotrophic Lateral Sclerosis (ALS) including progression, survival and cognition remain poorly defined and may depend on its metabolization influenced by genetic variants. 378 ALS patients with a precise evaluation of their regular caffeine consumption were monitored as part of a prospective multicenter study. Demographic, clinical characteristics, functional disability as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
